BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 12270982)

  • 1. Follow-up and treatment of adults with cystinosis in the Netherlands.
    Geelen JM; Monnens LA; Levtchenko EN
    Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
    Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classic nephropathic cystinosis as an adult disease.
    Theodoropoulos DS; Krasnewich D; Kaiser-Kupfer MI; Gahl WA
    JAMA; 1993 Nov; 270(18):2200-4. PubMed ID: 8411603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome.
    Levtchenko EN; de Graaf-Hess A; Blom HJ; Monnens LA
    Clin Nephrol; 2002 May; 57(5):349-51. PubMed ID: 12036193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cystinosis in adults: A systemic disease].
    Servais A; Goizet C; Bertholet-Thomas A; Decramer S; Llanas B; Choukroun G; Novo R
    Nephrol Ther; 2015 Jun; 11(3):152-9. PubMed ID: 25769364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.
    Gahl WA; Balog JZ; Kleta R
    Ann Intern Med; 2007 Aug; 147(4):242-50. PubMed ID: 17709758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
    Nesterova G; Williams C; Bernardini I; Gahl WA
    Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
    Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
    Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.
    Hohenfellner K; Nießl C; Haffner D; Oh J; Okorn C; Palm K; Schlingmann KP; Wygoda S; Gahl WA
    Mol Genet Metab; 2022 Aug; 136(4):282-288. PubMed ID: 35843134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIH conference. Cystinosis: progress in a prototypic disease.
    Gahl WA; Thoene JG; Schneider JA; O'Regan S; Kaiser-Kupfer MI; Kuwabara T
    Ann Intern Med; 1988 Oct; 109(7):557-69. PubMed ID: 3048161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.
    Berryhill A; Bhamre S; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Transplant; 2016 Feb; 20(1):141-5. PubMed ID: 26477696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
    Ahlenstiel-Grunow T; Kanzelmeyer NK; Froede K; Kreuzer M; Drube J; Lerch C; Pape L
    Pediatr Nephrol; 2017 Jan; 32(1):91-97. PubMed ID: 27350621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system complications in adult cystinosis patients.
    Servais A; Saitovitch A; Hummel A; Boisgontier J; Scemla A; Sberro-Soussan R; Snanoudj R; Lemaitre H; Legendre C; Pontoizeau C; Antignac C; Anglicheau D; Funalot B; Boddaert N
    J Inherit Metab Dis; 2020 Mar; 43(2):348-356. PubMed ID: 31444911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of nephropathic cystinosis with cysteamine.
    Kleta R; Gahl WA
    Expert Opin Pharmacother; 2004 Nov; 5(11):2255-62. PubMed ID: 15500372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrarenal complications of cystinosis.
    Topaloglu R
    Pediatr Nephrol; 2024 Aug; 39(8):2283-2292. PubMed ID: 38127152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile cystinosis: From dialysis to renal transplantation.
    Jellouli M; Ferjani M; Abidi K; Zarrouk C; Abdelmoula J; Gargah T
    Saudi J Kidney Dis Transpl; 2017; 28(5):1180-1183. PubMed ID: 28937083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephropathic cystinosis: late complications of a multisystemic disease.
    Nesterova G; Gahl W
    Pediatr Nephrol; 2008 Jun; 23(6):863-78. PubMed ID: 18008091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of ocular manifestations in nephropathic cystinosis: a long-term study of a population treated with cysteamine.
    Dureau P; Broyer M; Dufier JL
    J Pediatr Ophthalmol Strabismus; 2003; 40(3):142-6. PubMed ID: 12795432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystinosis in adult and adolescent patients: Recommendations for the comprehensive care of cystinosis.
    Ariceta G; Camacho JA; Fernández-Obispo M; Fernández-Polo A; Gamez J; García-Villoria J; Lara Monteczuma E; Leyes P; Martín-Begué N; Oppenheimer F; Perelló M; Morell GP; Torra R; Santandreu AV; Güell A;
    Nefrologia; 2015; 35(3):304-21. PubMed ID: 26523297
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.